Shared on 07 Nov 25
Fair value Increased 0.31%MYCR: Net Profit Margins And Orders Will Support Steady Outlook Through 2025
Analysts have slightly raised their price target for Mycronic from SEK 216.67 to SEK 217.33. They cite improved profit margin forecasts and a more favorable future price-to-earnings outlook.
Shared on 24 Oct 25
Fair value Increased 4.67%Analyst Price Target Update for Mycronic Analysts have raised their fair value estimate for Mycronic from SEK 207.00 to SEK 216.67. This update reflects improved revenue growth projections, even though there is a slightly higher discount rate and lower profit margin expectations.
Shared on 10 Oct 25
Fair value Decreased 13%Narrative Update on Mycronic: Analyst Price Target Revision Analysts have revised their price target for Mycronic downward by SEK 31, from SEK 238 to SEK 207. This adjustment is based on updated forecasts for slower revenue growth and slightly softer profit margins.
Shared on 27 Aug 25
Fair value Increased 3.70%The increase in Mycronic's consensus price target to SEK238.00 reflects improved revenue growth forecasts and a modestly higher future P/E multiple. What's in the News Mycronic updated its 2025 revenue guidance, reverting to its original estimate of SEK 7.5 billion in net sales, compared to the previous range of SEK 7.0 to 7.5 billion.
Shared on 29 Jul 25
Fair value Decreased 6.60%The downward revision in Mycronic's analyst price target reflects notably softer outlooks for both revenue growth and net profit margin, resulting in a reduced fair value from SEK245.73 to SEK229.50. What's in the News Mycronic increased its 2025 net sales guidance to SEK 7.5 billion, restoring its original outlook.
Shared on 01 May 25
Fair value Decreased 9.16%AnalystConsensusTarget has decreased revenue growth from 6.2% to 3.7%.
Shared on 23 Apr 25
Fair value Decreased 1.33%AnalystConsensusTarget has decreased revenue growth from 8.3% to 6.2% and decreased shares outstanding growth rate from 0.0% to -0.0%.
Shared on 17 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
Fair value Increased 19%AnalystConsensusTarget has increased revenue growth from 3.5% to 8.3% and increased shares outstanding growth rate from -0.0% to 0.0%.
Shared on 26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
Fair value Decreased 0.16%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 12 Mar 25
Fair value Decreased 46%AnalystConsensusTarget has increased revenue growth from 6.3% to 9.0%.